跳至主要内容
临床试验/NCT02888691
NCT02888691已完成不适用

Low Carbohydrate Diet vs. High Carbohydrate Diet in Type 1 Diabetes: A Randomized Crossover Study

Hvidovre University Hospital2 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2016年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
14
试验地点
2
主要终点
Percentage of Time Spent in Euglycemia

研究概览

简要总结

The aim of the study is to investigate glycemic control during a low carbohydrate diet compared with during a high carbohydrate diet in adults with insulin pump treated type 1 diabetes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Type 1 diabetes ≥3 years
  • Insulin pump use ≥1 year
  • HbA1c ≥53 mmol/mol (7.0%)
  • BMI 20-27 kg/m2
  • Willingness to count carbohydrates and use the insulin pump bolus calculator for all boluses during the intervention periods
  • Willingness to use continuous glucose monitoring consistently during the intervention periods

排除标准

  • Females of childbearing potential who are pregnant, breast-feeding or intend to become pregnant or are not using adequate contraceptive methods
  • Use of SGLT-2-inhibitors
  • Use of corticosteroids during or within 30 days prior to the intervention periods
  • Celiac disease
  • Inflammatory bowel disease
  • Macroalbuminuria
  • Active proliferative retinopathy combined with an HbA1c ≥ 75 mmol/mol (9.0%)
  • Known or suspected alcohol or drug abuse
  • Other concomitant medical or psychological condition that according to the investigator's assessment makes the patient unsuitable for study participation

结局指标

主要结局

Percentage of Time Spent in Euglycemia

时间窗: 12 weeks - from baseline to end of study

Time spent with glucose values 4.0-10.0 mmol/l assessed by continuous glucose monitoring

次要结局

  • Magnesium(12 weeks - from baseline to end of study)
  • IL-6(12 weeks - from baseline to end of study)
  • Coefficient of Variation of Glucose(12 weeks - from baseline to end of study)
  • Change in A1c(From baseline to 12 weeks)
  • Total Daily Dose(12 weeks - from baseline to end of study)
  • Supar(12 weeks - from baseline to end of study)
  • Mean Amplitude of Glycemic Excursions(12 weeks - from baseline to end of study)
  • AUC Low(12 weeks - from baseline to end of study)
  • Weight(12 weeks - from baseline to end of study)
  • Time Spent in Hyperglycemia(12 weeks - from baseline to end of study)
  • AUC High(12 weeks - from baseline to end of study)
  • Post Breakfast Glucose Excursion(12 weeks - from baseline to end of study)
  • Total Daily Basal Insulin 24 Hour(12 weeks - from baseline to end of study)
  • Total Nightime Basal Insulin(From baseline to 12 weeks)
  • Total Daytime Basal Insulin(12 weeks - from baseline to end of study)
  • Total Daily Bolus Insulin(12 weeks - from baseline to end of study)
  • Mean Glucose(12 weeks - from baseline to end of study)
  • Standard Deviation of Glucose(12 weeks - from baseline to end of study)
  • Time Spent in Hypoglycemia(12 weeks - from baseline to end of study)
  • Severe Hypoglycemia(From baseline to 12 weeks)
  • Cholesterol(12 weeks - from baseline to end of study)
  • HDL(12 weeks - from baseline to end of study)
  • Albumin(12 weeks - from baseline to end of study)
  • Zinc(12 weeks - from baseline to end of study)
  • Carbohydrate Servings(12 weeks - from baseline to end of study)
  • Heart Rate(12 weeks - from baseline to end of study)
  • Free Fatty Acids(12 weeks - from baseline to end of study)
  • Potassium(12 weeks - from baseline to end of study)
  • Iron(12 weeks - from baseline to end of study)
  • Transferrin(12 weeks - from baseline to end of study)
  • IL-1(12 weeks - from baseline to end of study)
  • Blood Glucose Readings(12 weeks - from baseline to end of study)
  • Body Composition(12 weeks - from baseline to end of study)
  • Diabetes Treatment Satisfaction(12 weeks - from baseline to end of study)
  • Hypoglycemia Fear(12 weeks - from baseline to end of study)
  • LDL(12 weeks - from baseline to end of study)
  • Creatinine(12 weeks - from baseline to end of study)
  • Thrombocytes(12 weeks - from baseline to end of study)
  • U-alb-crea Ratio(12 weeks - from baseline to end of study)
  • Hip Circumference(12 weeks - from baseline to end of study)
  • Waist Circumference(From baseline to 12 weeks)
  • Systolic Blood Pressure(12 weeks - from baseline to end of study)
  • Diastolic Blood Pressure(12 weeks - from baseline to end of study)
  • Triglycerides(12 weeks - from baseline to end of study)
  • Urate(12 weeks - from baseline to end of study)
  • Hemoglobin(12 weeks - from baseline to end of study)
  • Leucocytes(12 weeks - from baseline to end of study)
  • Ferritin(12 weeks - from baseline to end of study)
  • Folate(12 weeks - from baseline to end of study)
  • TNF-alpha(12 weeks - from baseline to end of study)
  • Sodium(12 weeks - from baseline to end of study)
  • Vitamin B-12(12 weeks - from baseline to end of study)
  • IL-8(12 weeks - from baseline to end of study)
  • CRP(12 weeks - from baseline to end of study)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Signe Schmidt

MD PhD

Copenhagen University Hospital, Hvidovre

研究点 (2)

Loading locations...

相似试验